How to update CPV parameter sets as processes and products evolve How to update CPV parameter sets as processes and products evolve Continued Process Verification (CPV) has become a critical aspect of pharmaceutical manufacturing as organizations aim for enhanced product quality throughout the lifecycle. As processes adapt and products evolve, it is imperative to revise CPV parameter sets to support ongoing Quality by Design (QbD) methodologies. This article will elaborate on the frameworks necessary for updating CPV parameters, addressing the selection of Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs), integration with Quality Target Product Profiles (QTPPs), and the…

CPV Parameters for Cleaning Validation, Hold Times and Equipment Reliability CPV Parameters for Cleaning Validation, Hold Times and Equipment Reliability Continued Process Verification (CPV) is an essential element in ensuring product quality and compliance in the pharmaceutical industry. As per FDA guidelines and European Medicines Agency (EMA) regulations, effective CPV can enhance lifecycle performance management through a scientific, risk-based approach that integrates data from multiple stages in the development and production processes. This article serves as a comprehensive guide to CPV parameters, focusing on cleaning validation, hold times, and equipment reliability, thereby catering to regulatory affairs, quality assurance, and clinical…

Internal Audits Focused on Traceability from Risk Assessments to CPV Lists Internal Audits Focused on Traceability from Risk Assessments to CPV Lists In the pharmaceutical industry, ensuring the integrity of product quality through rigorous auditing and monitoring mechanisms is essential for compliance with regulatory requirements, particularly those outlined by the FDA and international regulatory bodies. This article delves into the intricacies of conducting internal audits that focus on traceability from risk assessments to Continued Process Verification (CPV) lists. This guide is crucial for professionals involved in quality assurance, regulatory affairs, and clinical operations, specifically within the context of CPV parameter…

Leveraging Design of Experiments (DOE) Outputs for CPV Parameter Prioritisation Leveraging Design of Experiments (DOE) Outputs for CPV Parameter Prioritisation Continued Process Verification (CPV) has emerged as a pivotal component of pharmaceutical quality management, contributing significantly to the establishment of robust quality systems. Central to the success of CPV is the effective selection of critical process parameters (CPPs) and critical quality attributes (CQAs), establishing a framework for continuous monitoring and control of manufacturing processes. The design of experiments (DOE) offers valuable insights that, when leveraged correctly, can enhance CPV parameter prioritisation and ultimately help ensure product quality throughout the product…

Templates for CPV Parameter Rationales, Impact Assessments and Justifications Templates for CPV Parameter Rationales, Impact Assessments and Justifications Continued Process Verification (CPV) is a critical component of modern pharmaceutical manufacturing, aiming to ensure that production processes remain in a state of control and consistently deliver high-quality products. This article provides a regulatory-style manual for the selection of CPV parameters, with an emphasis on templates for rationales, impact assessments, and justifications. The content aligns with FDA regulations, EMA guidelines, and MHRA expectations, making it relevant for professionals in regulatory affairs, clinical operations, and medical affairs in the US, UK, and EU….

Global expectations for science and risk based CPV parameter selection Global Expectations for Science and Risk Based CPV Parameter Selection In an increasingly regulated pharmaceutical landscape, Continued Process Verification (CPV) presents an essential framework for assuring product quality throughout the lifecycle of drug manufacturing. As per FDA guidelines, Compassionate use, CQA monitoring, and CPV parameter selection are vital components aligned with the Quality by Design (QbD) principles laid out in ICH Q8(R2). This article aims to elucidate the regulatory expectations surrounding CPV parameter selection while offering a comprehensive examination of Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs), necessary…

Future of CPV Parameter Selection: Data-Driven, Model-Assisted, and Adaptive Future of CPV Parameter Selection: Data-Driven, Model-Assisted, and Adaptive In the pharmaceutical industry, Continued Process Verification (CPV) has emerged as a critical component in ensuring product quality and compliance with regulatory requirements. The selection of critical process parameters (CPPs) and critical quality attributes (CQAs) for monitoring is paramount to a robust CPV strategy. As the industry evolves, so too does the need for more sophisticated, data-driven, and adaptive approaches to CPV parameter selection. In this article, we detail the principles and methodologies involved in modern CPV parameter selection, emphasizing quality by…

Common pitfalls in CQA CPP mapping that weaken CPV programs Common Pitfalls in CQA CPP Mapping That Weaken CPV Programs In the pharmaceutical industry, the necessity for ensuring consistent product quality while adapting to evolving regulatory guidelines is paramount. Continued Process Verification (CPV) offers a framework for monitoring and ensuring quality across the product lifecycle. However, there are notable common pitfalls in the mapping of Critical Quality Attributes (CQAs) to Critical Process Parameters (CPPs) that can undermine CPV efforts. This article delves into these challenges, explores the linkage between CQAs and CPPs, and offers guidance for optimizing parameter selection to…

Training SMEs on Robust CQA and CPP Identification Feeding into CPV Training SMEs on Robust CQA and CPP Identification Feeding into CPV In the pharmaceutical industry, the selection and monitoring of Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) are vital components of a successful Continued Process Verification (CPV) program. The integration of Quality by Design (QbD) principles enhances the understanding of the relationship between CQAs and CPPs, thereby ensuring product quality throughout the product lifecycle. This article aims to provide a structured approach for training Subject Matter Experts (SMEs) in identifying robust CQAs and CPPs that align with…

Using Multivariate Analysis to Refine CPV Parameter Significance Over Time Using Multivariate Analysis to Refine CPV Parameter Significance Over Time In the pharmaceutical industry, the importance of Continued Process Verification (CPV) cannot be understated. It plays a critical role in maintaining the quality and efficacy of drug products throughout their lifecycle. The refinement of CPV parameter significance is a complex process that requires a robust understanding of various analytical techniques, particularly multivariate analysis, which can enhance the evaluation of Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs). This comprehensive article provides a detailed overview of using multivariate analysis to…